Buprenorphine 00228-3153
Product NDC
00228-3153- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- February 19, 2015
- Listing Expires
- December 31, 2027
- Application
- ANDA090819
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Packaging Options(1)
30 TABLET in 1 BOTTLE (0228-3153-03)